Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Kazutoshi Mori and Peter Walter receive the 2014 Albert Lasker Basic Medical Research Award
Corinne L. Williams
Corinne L. Williams
Published September 8, 2014
Citation Information: J Clin Invest. 2014;124(10):4138-4142. https://doi.org/10.1172/JCI78419.
View: Text | PDF
News

Kazutoshi Mori and Peter Walter receive the 2014 Albert Lasker Basic Medical Research Award

  • Text
  • PDF
Abstract

Authors

Corinne L. Williams

×

Figure 2

Simplified schematic of the three pathways that mediate the UPR in mammalian cells.

Options: View larger image (or click on image) Download as PowerPoint
Simplified schematic of the three pathways that mediate the UPR in mamma...
Under homeostatic conditions, transmembrane proteins IRE1, ATF6, and PERK reside within the ER membrane, and their lumenal domains bind the protein-folding chaperone BiP. The accumulation of unfolded proteins in the ER triggers alterations of these proteins that result in transcriptional and translational changes in the cell that either deal with the excess unfolded proteins in the ER or promote apoptosis. Upon activation, PERK phosphorylates the translation initiation factor eIF2α, which reduces global translation but promotes translation of the transcription factor ATF4. Activation of IRE1 results in oligomerization, autophosphorylation, and RNA splicing activity. IRE1 specifically splices XBP1 mRNA, which is then relegated and translated. XBP1 then induces transcription of genes involved in the UPR. In response to unfolded proteins, ATF6 is targeted to the Golgi apparatus via vesicular transport. Once in the Golgi, AFT6 is cleaved by S1P and S2P, allowing the cytoplasmic portion of the protein to enter the nucleus and mediate transcription of UPR-associated genes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts